08:58 AM EDT, 09/05/2025 (MT Newswires) -- Health care stocks were advancing pre-bell Friday, with the Health Care Select Sector SPDR Fund (XLV) up 0.1% and the iShares Biotechnology ETF (IBB) 0.8% higher.

BioNTech (BNTX) shares were up more than 9% after the company and China's Duality Biologics said their phase 3 trial evaluating trastuzumab pamirtecan in patients with a certain type of breast cancer met its primary endpoint in an interim analysis.